December 2015: The Antibody Update

This month's Antibody Update includes the highlights of the Antibody Engineering and Therapeutics conference, Jimmy Carter's cancer remission, and another cancer antibody designed to target CD-47.

November 2015: The Antibody Update

This month's Antibody Update looks into bacteria resistant to our most powerful antibiotics, targetting of MRSA with antibody drug conjugates, and the international summit on Human Genome Editing regarding CRISPR use.

Tips for Understanding the Reproducibility Crisis

An article published by Nature pointed out that researchers should worry about the reproducibility of production antibodies. Antibodies are finicky molecules due to their high binding specificity, and even one discrepancy in either production or application can alter the result of an experiment. Learn how to avoid problems with reproducibility here!

The 5 A's of Antibody Development

The 5 A’s of Antibody Development as the basis of our custom antibody services, we are able to create antibodies for even the most difficult antigens. This infographic will serve as a brief description of each of the 5 A’s and the options therein. 

October 2015: Antibody Update

Read about an antibody against an Alzheimer’s associate protein that was announced at SfN 2015, how green sea turtles have asymmetrical IgY antibodies with new immunochemistry, and the FDA approval of the first virus based treatment of cancer in this Antibody Update!

Antibody Basics: Hybridoma Development

Hybridoma technology is the core technique that is used for monoclonal antibody development. By isolating B-cells from mice and fusing them with tumor cells, immortal cell lines are able to be grown and used for production purposes. Learn more about hybridoma protocol on ProSci's blog.

September 2015: Antibody Update

The September Antibody Update includes news on an antibody targetting HIV glycoproteins at different conformations, a paper on humanized monoclonal antibodies against clostridium difficile finishing phase 3 clinical trials, and the study of a human endogenous retrovirus that may reveal understanding of ALS.

ProSci's Antibody Expert's Published in Vaccine!

Last month, the latest ProSci research on the HIV vaccine development was published in the scientific journal Vaccine. Here is a background on the work ProSci has done developing a vaccine against the HIV glycoproteins.

 August 2015: The Antibody Update

August's Antibody Update looks at Cornell University's "Shuffle" method of mimicking primary imune responses in vitro.